eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Document ID:
DEA-2012-0007-0001
Document Type:
Proposed Rule
Agency:
Drug Enforcement Administration
Topics:
Administrative Practices and Procedures, Drug Traffic Control, Reporting and Recordkeeping Requirements
CFR Citation:
21 CFR Part 1308
View Document:
Details Information
Received Date:
December 19 2012, at 09:53 AM Eastern Standard Time
Start-End Page:
75075 - 75079
Comment Start Date:
December 19 2012, at 12:00 AM Eastern Standard Time
Comment Due Date:
January 18 2013, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
68
Comment on FR Doc # 2012-30531
Submitter:
Dedvukaj, Joseph
Posted:
12/21/2012
ID:
DEA-2012-0007-0003
Comment Period Closed
Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Submitter:
Caruso, Kevin
Posted:
12/21/2012
ID:
DEA-2012-0007-0004
Comment Period Closed
Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Submitter:
Viola, John
Posted:
12/21/2012
ID:
DEA-2012-0007-0005
Comment Period Closed
Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Submitter:
GANJAVI, REZA
Posted:
12/21/2012
ID:
DEA-2012-0007-0008
Comment Period Closed
Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Submitter:
Mansbach, Robert
Posted:
01/04/2013
ID:
DEA-2012-0007-0032
Comment Period Closed
Jan 18,2013 11:59 PM ET
Related Documents
More
Total:
32
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Establishment of Drug Codes for 26 Substances
Schedules of Controlled Substances: Extension of Temporary Placement of Methylone Into Schedule I
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act
Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V
Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Schedules of Controlled Substances: Placement of Ezogabine into Schedule V
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Establishment of a New Drug Code for Marihuana Extract
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I; Correction
Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of Controlled Substances Act
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Listing of Approved Drug Products Containing Dronabinol in Schedule III
Schedules of Controlled Substances: Placement of Propofol into Schedule IV
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances
Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira
Schedules of Controlled Substances: Placement of Carisoprodol into Schedule IV; Announcement of Hearing
Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC
Schedules of Controlled Substances: Placement of Fospropofol into Schedule IV
Schedules of Controlled Substances: Placement of Lacosamide into Schedule V
Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Details Information
Comments
View AllSubmitter: Dedvukaj, Joseph Posted: 12/21/2012 ID: DEA-2012-0007-0003
Jan 18,2013 11:59 PM ET
Submitter: Caruso, Kevin Posted: 12/21/2012 ID: DEA-2012-0007-0004
Jan 18,2013 11:59 PM ET
Submitter: Viola, John Posted: 12/21/2012 ID: DEA-2012-0007-0005
Jan 18,2013 11:59 PM ET
Submitter: GANJAVI, REZA Posted: 12/21/2012 ID: DEA-2012-0007-0008
Jan 18,2013 11:59 PM ET
Submitter: Mansbach, Robert Posted: 01/04/2013 ID: DEA-2012-0007-0032
Jan 18,2013 11:59 PM ET
Related Documents
More